<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Kaldara, E.</style></author><author><style face="normal" font="default" size="100%">Sanoudou, D.</style></author><author><style face="normal" font="default" size="100%">Adamopoulos, S</style></author><author><style face="normal" font="default" size="100%">Nanas, J.N.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Outpatient management of chronic heart failure</style></title><secondary-title><style face="normal" font="default" size="100%">Expert Opin PharmacotherExpert Opin PharmacotherExpert Opin Pharmacother</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Expert opinion on pharmacotherapy</style></alt-title><short-title><style face="normal" font="default" size="100%">Expert opinion on pharmacotherapyExpert opinion on pharmacotherapy</style></short-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Adrenergic beta-Antagonists/therapeutic use</style></keyword><keyword><style  face="normal" font="default" size="100%">Angiotensin-Converting Enzyme Inhibitors/therapeutic use</style></keyword><keyword><style  face="normal" font="default" size="100%">Chronic Disease</style></keyword><keyword><style  face="normal" font="default" size="100%">Clinical Trials as Topic</style></keyword><keyword><style  face="normal" font="default" size="100%">Disease Management</style></keyword><keyword><style  face="normal" font="default" size="100%">Heart Failure/*drug therapy/etiology</style></keyword><keyword><style  face="normal" font="default" size="100%">Humans</style></keyword><keyword><style  face="normal" font="default" size="100%">Outpatients</style></keyword><keyword><style  face="normal" font="default" size="100%">Ventricular Dysfunction, Left/complications/drug therapy</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">Jan</style></date></pub-dates></dates><number><style face="normal" font="default" size="100%">1</style></number><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">17-41</style></pages><isbn><style face="normal" font="default" size="100%">1744-7666 (Electronic)1465-6566 (Linking)</style></isbn><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">INTRODUCTION: Heart failure (HF) treatment attracts a share of intensive research because of its poor HF prognosis. In the past decades, the prognosis of HF has improved considerably, mainly as a consequence of the progress that has been made in the pharmacological management of HF. AREAS COVERED: This article reviews the outpatient pharmacological management of chronic HF due to left ventricular systolic dysfunction and offers recommendations on the use of various drugs. In addition, the present article attempts to provide practical therapeutic algorithms based on current clinical strategies. EXPERT OPINION: Continued research directed toward identifying factors associated with high pharmacotherapy guideline adherence and understanding of variants that influence response to drugs will hopefully halt or reverse the major pathophysiological mechanisms involved in this syndrome.</style></abstract><accession-num><style face="normal" font="default" size="100%">25480690</style></accession-num><notes><style face="normal" font="default" size="100%">Kaldara, ElisabethSanoudou, DespinaAdamopoulos, StamatisNanas, John NengReviewEngland2014/12/07 06:00Expert Opin Pharmacother. 2015 Jan;16(1):17-41. doi: 10.1517/14656566.2015.978286. Epub 2014 Dec 5.</style></notes><auth-address><style face="normal" font="default" size="100%">University of Athens, Medical School, 3rd Cardiology Department , Mikras Asias 67, 11527 Attiki, Athens , Greece +30 2108236877 ; +30 2107789901 ; inanas@med.uoa.gr.</style></auth-address></record></records></xml>